2023-12990. Healthcare Infection Control Practices Advisory Committee (HICPAC); Correction

AGENCY:

Centers for Disease Control and Prevention, Department of Health and Human Services (HHS).

ACTION:

Notice.

SUMMARY:

In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC). This is a virtual meeting. The public is welcomed to listen to the meeting via Zoom; 500 teleconference lines are available. Time will be available for public comment. Registration is required.

FOR FURTHER INFORMATION CONTACT:

Sydnee Byrd, M.P.A., HICPAC, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, l600 Clifton Road NE, Mailstop H16–3, Atlanta, Georgia 30329. Telephone [phone]; Email: [e-mail].

SUPPLEMENTARY INFORMATION:

Notice is hereby given of a change in the meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC); June 8, 2023, 9:00 a.m. to 5:00 p.m., EDT, and June 9, 2023, 9:00 a.m. to 12:00 p.m., EDT in the original FRN.

The virtual meeting was published in the Federal Register on May 1, 2023, Volume 88, Number 83, page/s/26547–26548.

The virtual meeting is being corrected to revise the SUMMARY , ADDRESSES , and SUPPLEMENTARY INFORMATION and should read as follows:

SUMMARY: In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC). This meeting will be virtual for all public attendees, limited only by audio and web conference lines (500 audio and web conference lines are available). Registration is required. To register for this web conference, please go to: www.cdc.gov/​hicpac. All registered participants will receive the meeting link and instructions shortly before the meeting.

ADDRESSES: Registration is required. All registered participants will receive instructions shortly before the meeting. Please click first link for day one and the second link for day two to join the webinar:

https://cdc.zoomgov.com/​j/​1616828862?​pwd=​N3hmSTEvQjQ3ZHFScVMyM1k2Mk8yUT09.

Meeting ID: 161 682 8862.

Passcode: 74249065.

https://cdc.zoomgov.com/​j/​1614944394?​pwd=​UWdBRDNNK2pDdS9PMjlMZzYvRVFzZz09.

Meeting ID: 161 494 4394.

Passcode: 26658671.

SUPPLEMENTARY INFORMATION:

Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion (DHQP), the Director, National Center for Emerging and Zoonotic Infectious Diseases, the Director, CDC, and the Secretary, Department of Health and Human Services, regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions.

Matters to be Considered: The agenda will include updates on CDC's activities for prevention of healthcare-associated infections. It will also include updates from the following HICPAC workgroups: the Isolation Precautions Guideline workgroup, the Dental Unit Waterline Guideline Workgroup, the Healthcare Personnel Guideline Workgroup, and the National Healthcare Safety Network Workgroup. The agenda also includes updates on CDC and DHQP activities. Agenda items are subject to change as priorities dictate.

Public Participation

Oral Public Comment: Time will be available for public comment. Members of the public who wish to provide public comments should plan to attend the public comment session at the start time listed. Please note that the public comment period may end before the time indicated, following the last call for comments.

Written Public Comment: The public is welcomed to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed above. The deadline for receipt of written public comment was May 26, 2023. All requests must contain the name, address, and organizational affiliation of the speaker, as well as the topic being addressed. Written comments should not exceed one single-spaced typed page in length and delivered in 3 minutes or less. Written comments received in advance of the meeting will be included in the official record of the meeting.

The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,

Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.